Evonik receives EU market clearance for AvailOm


The nutraceutical partner has received European clearance to market its high-load Omega-3 powder for use in supplements

Evonik receives EU market clearance for AvailOm

Evonik, a global partner to nutraceutical companies for advanced food ingredients and formulation development services, has received clearance to market its innovative high-concentration Omega-3 lysine powder complex AvailOm for use in the European Union (EU).

AvailOm is the highest-load Omega-3 powder in its class with a minimum of 45% EPA and DHA by weight. A single, small tablet made from AvailOm can deliver the same Omega-3 fatty acid uptake as two large fish oil softgel capsules.

Like this story? Subscribe to Nutraceutical Business Review magazine for incisive analysis, the latest news and expert-written articles from the functional food and drink industries. For more information click here.

In addition to delivering unmatched protection against oxidation based upon 3 years of stability data, it is also direct compressible and can be customised to meet specific formulation requirements.

Sign up for your free email newsletter

Cornelis van den Muyzenberg, VP of Food Ingredients and Strategic Projects at Evonik Health Care, said: “The superior potency, bioavailability and stability of AvailOm creates a significant opportunity for nutraceutical companies to develop single and multi-ingredient consumer-friendly supplements. We look forward to supporting customers develop new formulations that are enabled by this innovative nutraceutical ingredient."